Louis Milione, the second-in-command at the U.S. Drug Enforcement Administration (DEA), has resigned after reports revealed his previous consulting work for pharmaceutical companies including Purdue Pharma, the maker of OxyContin. Milione's consulting work for Purdue Pharma and a drug distributor that failed to flag suspicious opioid orders has raised concerns about the revolving door between government and the pharmaceutical industry. Milione had returned to the DEA in 2021 as the top deputy to Administrator Anne Milgram. The DEA has faced criticism for not filling the position of deputy administrator that requires Senate confirmation.

The post DEA official Resigns Amid Reports of Previous Big Pharma consulting work appeared first on Balanced News Summary.